Literature DB >> 24573040

[Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP)].

S B Harrabi1, M W Büchler, J Werner, S E Combs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24573040     DOI： 10.1007/s00066-013-0533-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  [S3-Guidelines "Exocrine pancreatic cancer" 2007].

Authors:  G Adler; T Seufferlein; S C Bischoff; H-J Brambs; S Feuerbach; G Grabenbauer; S Hahn; V Heinemann; W Hohenberger; J M Langrehr; M P Lutz; O Micke; H Neuhaus; P Neuhaus; H Oettle; P M Schlag; R Schmid; W Schmiegel; K Schlottmann; J Werner; B Wiedenmann; I Kopp
Journal:  Z Gastroenterol       Date:  2007-06       Impact factor: 2.000

2.  Chemoradiotherapy for locally advanced pancreatic cancer.

Authors:  Markus K Diener; Stephanie E Combs; Markus W Büchler
Journal:  Lancet Oncol       Date:  2013-03-06       Impact factor: 41.316

3.  Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.

Authors:  Susannah Yovino; Matthew Poppe; Salma Jabbour; Vera David; Michael Garofalo; Naimesh Pandya; Richard Alexander; Nader Hanna; William F Regine
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

Review 4.  Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.

Authors:  Sonja Gillen; Tibor Schuster; Christian Meyer Zum Büschenfelde; Helmut Friess; Jörg Kleeff
Journal:  PLoS Med       Date:  2010-04-20       Impact factor: 11.069

5.  Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

Authors:  Daniel Habermehl; Kerstin Kessel; Thomas Welzel; Holger Hof; Amir Abdollahi; Frank Bergmann; Stefan Rieken; Jürgen Weitz; Jens Werner; Peter Schirmacher; Markus W Büchler; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-03-02       Impact factor: 3.481

6.  Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.

Authors:  Somnath Mukherjee; Christopher N Hurt; John Bridgewater; Stephen Falk; Sebastian Cummins; Harpreet Wasan; Tom Crosby; Catherine Jephcott; Rajarshi Roy; Ganesh Radhakrishna; Alec McDonald; Ruby Ray; George Joseph; John Staffurth; Ross A Abrams; Gareth Griffiths; Tim Maughan
Journal:  Lancet Oncol       Date:  2013-03-06       Impact factor: 41.316
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.